Abstract

AbstractThis study was carried out to determine whether the treatment of anther‐culture‐derived haploid callus of maize (Zea mays) with chromosome‐doubling agents, such as colchicine or the herbicides pronamide and amiprophos‐methyl (APM), induces higher than normal levels of somaclonal variation. A total of 79 R1 families produced by diploid regenerated plants resulting from chromosome‐doubling treatments were evaluated in the field in comparison with the three parental inbreds.Four qualitative variant phenotypes — male sterility, chlorophyll deficiency, earless plants, and short plants with narrow leaves and thin stalks —– were observed. The last phenotype (narrow leaves and thin stalks) was also found in the inbreds FR16 and H99 grown from seed, so it may not be directly related to the tissue‐culture conditions or the anti‐microtubule‐agent treatments. The frequency of R1 families segregating for the other three mutations was 3.8%, which is no higher than the somaclonal variation frequencies observed previously in tissue‐culture‐derived maize plants. Observations of three quantitative traits—–days to anthesis, days to silk emergence, and plant height—– also failed to detect any extra variation that could be related to the treatments with anti‐microtubule agents. These studies indicate that the anti‐microtubule agents APM, pronamide and colchicine can be used to induce chromosome doubling of anther‐culture‐derived callus to produce a high proportion of doubled haploid plants without causing increased rates of mutation (somaclonal variation).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call